After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, CRGX falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of CARGO Therapeutics Inc is $195.98M. A total of 0.79 million shares were traded on the day, compared to an average of 750.80K shares.
In the most recent transaction, Radhakrishnan Anup sold 27,404 shares of CRGX for 3.84 per share on May 14 ’25. After the transaction, the insider now owns 122,413 company shares. In a previous transaction on Apr 03 ’25, Radhakrishnan Anup sold 1,629 shares at 4.00 per share. CRGX shares that the insider owns now total 77,317.
Among the insiders who sold shares, Chapman Gina disposed of 7,166 shares on Sep 18 ’24 at a per-share price of $25.09. This resulted in the President & CEO holding 103,905 shares of CRGX after the transaction. In another insider transaction, Chapman Gina sold 2,975 shares at $25.03 per share on Sep 19 ’24. Company shares held by the President & CEO now total 103,905.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, CRGX has a high of $25.45 and a low of $3.00.
As of this writing, CRGX has an earnings estimate of -$0.48 per share for the current quarter. EPS was calculated based on a consensus of 3.0 estimates, with a high estimate of -$0.37 per share and a lower estimate of -$0.6.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. CRGX’s latest balance sheet shows that the firm has $41.00k in Cash & Short Term Investments as of fiscal 2021. There were $3.17M in debt and $2.45M in liabilities at the time. Its Book Value Per Share was $6.13, while its Total Shareholder’s Equity was -$175.00k.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CRGX is Buy with a score of 2.60.
